Top News

  • IU School of Medicine, IU Health establish new institutes, appoint leaders

    As part of their continued alignment, IU School of Medicine and IU Health are jointly establishing new cardiovascular, neuroscience and cancer institutes. The idea for the institutes was born out of extensive study about how the school and the health system should align as an enterprise to foster a culture of innovation and excellence, and to best meet the needs of patients.

    In the announcement emailed to colleagues this week, IU School of Medicine Dean Jay L. Hess, MD, PhD, MHSA, and Dennis Murphy, president and CEO, IU Health, broadly defined the institutes, explaining, “These umbrella entities transcend multiple departments and are designed to maximize synergies between education, research and clinical care. The goal is to fully realize the promise of academic medicine to better address the most pressing challenges facing patients.”

    Related to the establishment of the three institutes, Hess and Murphy shared the following leadership announcements:

    Subha Raman, MD, MSEE, joined IU School of Medicine on February 1 as director of the Cardiovascular Institute

    The Neuroscience Institute will be led by a trio of co-directors that includes Shelly Timmons, MD, PhD, the school’s new chair of neurosurgery; Bruce Lamb, PhD, executive director of the Stark Neurosciences Research Institute; and Robert Pascuzzi, MD, chair of neurology. Pascuzzi is planning to step back from his leadership roles once a successor is named, and the next neurology chair will join the institute’s leadership team.

    The Cancer Institute will be led by the next director of the IU Simon Cancer Center for which a national search is currently underway.

    “The institute directors and co-directors will be responsible for developing strategy across our tripartite mission,” Hess and Murphy explained. “The initial focus will be on the Academic Health Center, though our vision is that their influence will grow to include the entire state and system. Importantly, the directors will be informed by an advisory committee that includes all related department chairs and other appropriate school and health system leaders.”

    Institute goals 

    • Grow multidisciplinary clinical programs
    • Develop focused Centers of Excellence
    • Provide consistency in care delivery and quality initiatives
    • Offer unique clinical programs in Indiana
    • Increase research and programmatic funding (NIH, training grants, etc.)
    • Develop Accreditation Council for Graduate Medical Education (ACGME) fellowships in strategic areas

    Hess and Murphy said IU School of Medicine and IU Health are exploring the merits of creating institutes in other strategic areas, such as musculoskeletal health and children’s health.

    Back to Top ▲

  • School names new senior associate dean for development and alumni relations

    A senior leader with extensive fundraising experience in varying academic medical settings has been named IU School of Medicine’s senior associate dean for development and alumni relations.

    Mark Notestine, PhD, has most recently served as associate vice chancellor, advancement and president of the Medical & Health Sciences Foundation at East Carolina University. He has held various senior leadership advancement positions at Dartmouth College in Hanover, New Hampshire, and Ohio State University. Notestine will assume his new role effective Monday, March 16.

    “The school’s Office of Gift Development is integral to our ability to improve health care in Indiana and beyond,” said Jay L. Hess, MD, PhD, MHSA, IU School of Medicine dean and executive vice president for University Clinical Affairs. “Mark’s skills and experience make him uniquely qualified to ensure our success well into the future. “

    For more on Notestine’s appointment, visit the Newsroom.

    Back to Top ▲

  • Registration now open for school’s first Education Day on March 6

    Aimed at bringing fresh perspectives to medical education, IU School of Medicine will host its first Education Day on Friday, March 6. The daylong event offers the opportunity for faculty, students, residents and fellows from all departments and campuses to showcase their medical education research through oral presentations and poster sessions.

    Invited speakers for the event are:

    Keynote speaker
    Susan E. Skochelak, MD, MPH, chief academic officer, group vice president, Medical Education
    American Medical Association
    “Medical Education Innovation: Roadmap for the Next Decade”

    Plenary speaker
    Michael A. Barone, MD, MPH, vice president, Licensure Programs
    National Board of Medical Examiners
    “USMLE Numeric Scoring: A 360 Assessment”

    Registration deadline is Friday, February 21. Registration instructions are available.

    CME credit for Education Day will be available. Read the blog post for a complete list of topics and more information. Questions? Email Komal Kochhar at kkochhar@iupui.edu.

    Back to Top ▲

  • Save the date: Inaugural Stephen P. Bogdewic lectureship is May 11

    The inaugural Stephen P. Bogdewic Lectureship in Medical Leadership, featuring keynote speaker Robert I. Grossman, MD, will be held on Monday, May 11, in the University Tower Ballroom on the IUPUI campus. The lectureship aims to provide faculty with an opportunity to listen to the journeys of successful leaders in medicine.

    One of the most accomplished leaders in academic medicine, Grossman is CEO of NYU Langone Health and dean of the NYU Grossman School of Medicine. In this role, he oversees more than 40,000 faculty and staff members across six inpatient locations and over 330 sites throughout the New York region and in Florida. Known as a “pathological optimist,” Grossman has led NYU Langone Health to become renowned for world-class patient care and fiscally sound management. His leadership philosophy centers on tapping into the aspirations of people to empower them with the confidence to succeed. 

    The Bogdewic lectureship was established to honor the career and contributions of longtime IU School of Medicine leader Stephen P. Bogdewic, who retired from the school in June 2019.

    Register for the May 11 lectureship.

    Back to Top ▲

  • New downtown shuttle tracker now available

    IU Health has launched a new real-time shuttle tracking system to make catching a ride on the downtown shuttle more convenient and timely. The new tracker provides a map of the downtown and express routes, real-time location of the shuttles and estimated arrival times. The new service, along with its back-end technology, aims to help shuttle operators space the shuttles more efficiently, leading to shorter wait times.

    Access the new shuttle tracking system online or download the tracking system app on your smart phone by searching for “IU Health shuttle” in your app store.

    DoubleMap, the original shuttle tracking system, will be available until Friday, February 14.

    Back to Top ▲

Research News

  • Cancer researchers receive $3 million in NIH grants to investigate cell functions within bone marrow

    More than $3 million from the National Institutes of Health will allow IU Simon Cancer Center researchers to improve understanding of the complex system of how hematopoietic stem cells (HSC) survive and sustain their function in the bone marrow.

    Edward F. Srour, PhD, the Robert J. and Annie S. Rohn Professor of Leukemia Research, and Melissa A. Kacena, PhD, professor of orthopaedic surgery, are building on a decade of research collaboration on how bone cells help HSC function.

    HSC, which produce red and white blood cells, reside in the bone marrow in the core of bones. The complex system of multiple cell types that are responsible for maintaining those stem cells is called the hematopoietic niche.

    “Years ago, we discovered that a molecule named CD166 is important for the maintenance of stem cells because it is also expressed on immature osteoblasts, the bone-forming cells that are an important component of the hematopoietic niche,” Srour said. Both young osteoblasts and stem cells interact together through CD166 to maintain stem cell function.

    Researchers know that the CD166 molecule is critical because stem cells lose activity without it, but for which cells is it most important and which don’t need it?

    With a $1.7 million grant from the National Institutes of Health, Srour and colleagues will delete CD166 from different cell types found in the hematopoietic niche to figure out where the molecule is essential and where it is not.

    IU Simon Cancer Center researchers are also investigating another cell type formed in the hematopoietic niche called osteomacs, which are a specialized bone-resident macrophage. Macrophages are vital to the immune system with the job of engulfing and destroying foreign pathogens and sometimes cancer cells.

    While macrophages reside in every tissue in the body, their jobs differ a little depending on location. Working inside the bones are specialized macrophages called osteomacs.

    “We found that osteomacs play an important role in sustaining the stem cell function within the niche of the bone marrow,” Srour said. “The major struggle we have with these cells is they look like and function like bone marrow macrophages, so there is no easy way for us to separate one from the other.”

    With a five-year, $1.5 million grant, Srour and colleagues aim to identify a molecule that allows them to separate osteomacs from macrophages.

    Visit the Newsroom for more on the research.

    Back to Top ▲

  • Team receives grant to study precision health’s impact on patient screening

    Colorectal cancer is the third leading cause of cancer-related deaths for both men and women in the United States, according to the American Cancer Society. Screening can save lives, but the rate of screening for colorectal cancer is low, less than 65 percent, which means thousands of people die unnecessarily every year. Peter H. Schwartz, MD, PhD, hopes to make an impact on that issue by using precision health, specifically by providing patients with information about their individual risk factors.

    “Our goals are to help patients and their providers make better decisions about what screening test to take and to increase the amount of screening, which is too low,” said Schwartz, who co-leads the Behavioral Science and Ethics cluster of the IU Precision Health Initiative (PHI).

    Schwartz says a patient’s risk of having an advanced colorectal neoplasm (ACN), which is a cancer or precancerous polyp, can determine which test would be best to take. A colonoscopy is more effective for people who are at high risk of having an ACN, while patients who are at low risk may only need a less invasive test. Schwartz says screening rates go up when patients evaluate all screening options, instead of just the more invasive colonoscopy. 

    The research team led by Schwartz uses characteristics including age, waist circumference and family history to determine an individual’s risk for having an ACN. With a new $2.7 million grant from Patient-Centered Outcomes Research Institute (PCORI), patients who take part in the study will get a personalized message through their electronic health record patient portal with a screening recommendation. 

    Learn more about the research in Precision Health.

    Back to Top ▲

Faculty and Staff News

  • Take note: Current guidelines on coronavirus

    As the new coronavirus (2019-nCoV) develops, Indiana University is planning ahead and closely monitoring the situation with the guidance of agencies like the Centers for Disease Control and Prevention (CDC) and the Indiana State Department of Health.

    Given the fact that the vast majority of current coronavirus infections are within China, as well as the travel advisories to China issued from both the CDC and the U.S. Department of State, IU is implementing restrictions on travel that align with this guidance. Announced in a January 31 public safety advisory, the university is suspending all travel to China for faculty, staff and students. The advisory noted the university may grant exceptions to those wanting to travel for humanitarian response to the pandemic.

    In addition, effective Monday, February 3, the CDC issued new guidance for travelers returning to the U.S. on or after February 3 to determine their risk of contracting the 2019-nCoV. IU will follow this guidance in responding to the 2019-nCoV outbreak and in advising IU community members.

    Of particular interest to IU School of Medicine faculty and staff is the following related information:

    Visiting scholars from China:
    The following guidelines have been put into effect to accommodate visiting scholars who are traveling to IU campuses from China. Any scholar arriving from China is required to reach out to Graham McKeen, assistant university director, IU Environmental Health and Safety, by phone (812-856-5482 or 812-325-7510) or email at gmckeen@iu.edu prior to physically arriving on campus. McKeen will work with each campus and/or campus health center to inform them of arriving scholars and relay any necessary information.

    Evaluation of patients who may be ill with or exposed to coronavirus:
    Refer to the Flowchart to Identify and Assess 2019 Novel Coronaviru
    Review the February 1 Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus 

    Visit the Protect IU website for more tips, information and frequently asked questions about the coronavirus. This News at IU article also offers more information about how IU is monitoring the situation.

    Back to Top ▲

  • Important reminder and steps for reporting IT incidents 24/7

    An emergency IT incident, such as violation of the Family Educational Rights and Privacy Act (FERPA) or the Health Insurance Portability and Accountability Act (HIPAA) should be reported immediately to a live person, no matter the time of day or night, weekday or weekend. Do not simply leave a message and wait for a return call.

    Who to call (Steps to take until you reach a live person)
    Step 1: University Information Policy Office (UIPO)/University Information Security Office (UISO) directly at 812-855-UIPO (8476) (during business hours)

    Step 2: UITS Network Operations Center at 812-855-3699 (24/7)
    Step 3: UITS Support Center at 812-855-6789 (24/7)

    When you reach the Support Center or Network Operations Center, ask staff to contact UITS Data Center Operations so that a page can be sent to the UIPO or UISO. A representative will call you back.

    Please also send an email to it-incident@iu.edu outlining the incident details.

    If you receive any media inquiries regarding the incident, please direct the media to the IU School of Medicine Office of Strategic Communications at 317-671-3117.

    Back to Top ▲

  • Eduroam now available at IU Health facilities

    IU Health facilities are now active on the Eduroam network. Eduroam (education roaming) is a secure, worldwide wireless network access system developed for the international research and education community.

    Eduroam is available at IU and many other universities across the state. With IU Health adding Eduroam, you can use your IU Health email address and password to connect to Eduroam at IU Health, IU and other participating facilities. 

    What you need to know

    • If you can't connect to the Eduroam network, make sure you are using your complete IU or IU Health email address and passphrase. If you suspect you entered your information incorrectly, try “forgetting” and re-adding the network. Troubleshoot your Eduroam connection.
    • When you connect for the first time, you may be prompted to accept a new security certificate.
    • Be sure your device has the latest updates to its wireless software.
    • If your device does not support WPA2 Enterprise, you will be unable to connect.

     Read more.

    Back to Top ▲

Opportunities

  • Apply by May 4 for biomedical research grant

    The biomedical research grant program is open to all IU School of Medicine faculty who are full time, regardless of tenure status, having an appointment of assistant/associate/full professor and assistant/associate/full scientist. In general, two categories of research projects will benefit from this program: research projects of investigators new to IU School of Medicine who do not yet have extramural funding and who need support to acquire the preliminary data necessary to compete for extramural funding; and research projects of established IU School of Medicine investigators who are between funding periods from extramural sources.

    Deadline to apply is Monday, May 4. More details are available.

    Back to Top ▲

  • Research enhancement grant applications due May 4

    The IU School of Medicine Research Enhancement Program is designed to stimulate research productivity at the statewide Centers for Medical Education (regional campuses), including the Bloomington Medical Sciences Program. All full-time center/medical sciences faculty, regardless of tenure status, who have an appointment of assistant/associate/full professor or assistant/associate/full scientist at time of submission, are eligible to apply for a research enhancement grant. Primary appointment must be in IU School of Medicine. Faculty in visiting ranks are not eligible for funding through this program.

    Application deadline is Monday, May 4. More details are available.

    Back to Top ▲

  • February 28 child psychiatry conference to focus on trauma and resilience

    The 43rd annual Arthur B. Richter Conference in Child Psychiatry, exploring issues related to childhood trauma and resilience, will be held on Friday, February 28, at the Ritz Charles in Carmel. Featured speaker is David J. Kolko, PhD, ABPP, professor of psychiatry, psychology, pediatrics and clinical and translational science, University of Pittsbugh School of Medicine. Registration is available.

    Back to Top ▲

Partner News

  • IU Health to use virtual care to expand rural access in several counties

    Two grants from the United States Department of Agriculture (USDA) will allow IU Health to care for more rural Hoosiers. The grants—totaling $698,450—will be used to purchase virtual care infrastructure, creating better access in six primary care offices and seven rural critical access hospitals in Clinton, White, Tipton, Orange, Lawrence, Blackford and Jay counties in Indiana.

    With the investments, IU Health will:

    • Implement an efficient, high-quality approach to care in the health system’s critical access hospitals by virtually providing evening and overnight hospitalist coverage for emergency department physicians—when deciding on admitting patients to the hospital—and inpatient coverage for existing and new admissions.
    • Increase the reach of the Virtual Care Behavioral Health Hub in rural critical access hospitals and primary care offices, giving more patients access to opioid/substance abuse treatment and behavioral health services.

     The initiatives will be implemented throughout 2020.

    Back to Top ▲